In past decades, anticancer research has led to remarkable results despite many of the
approved drugs still being characterized by high systemic toxicity mainly due to the lack of …

Enteral administration is the most convenient route despite the gastrointestinal physiological
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …

Breast cancer is one of the most common types of cancer among women globally. It is
caused by mutations in the estrogen/progesterone receptors and conventional treatment …

The most frequent malignant tumor in women is breast cancer, and its incidence has been
rising every year. Propolis has been used for its antibacterial, antifungal, and anti …

The lipid-based colloidal carriers, such as nanostructured lipid carriers (NLCs), solid lipid
nanoparticles (SLNs), nanocapsules, liposomes, and microemulsion, are the latest and …

This study investigated the potential hepatoprotective activity of curcumin-incorporated nano-
lipid carrier (Cur-NLC) against cypermethrin (Cyp) toxicity in adult Wistar male rats. All …

Gefitinib (GEF) is utilized in clinical settings for the treatment of metastatic lung cancer.
However, premature drug release from nanoparticles in vivo increases the exposure of …

Cancer, characterized by uncontrolled cell growth and proliferation, continues to be a major
global health concern. Breast cancer, the most commonly diagnosed cancer among women …

According to the WHO, cancer caused almost 10 million deaths worldwide in 2020, ie,
almost one in six deaths. Among the most common are breast, lung, colon and rectal and …

Abstract Heme oxygenase-1 (HO-1) has been identified as a potential new target in
anticancer therapy, being overexpressed in different tumors and crucial for cell proliferation …